Clinical Study to Evaluate the Efficacy and Safety of Aliskiren Alone and in Combination With Hydrochlorothiazide in Patients With Essential Hypertension.

PHASE3CompletedINTERVENTIONAL

Enrollment

2,775

Participants

Timeline

Start Date

August 31, 2004

Primary Completion Date

June 30, 2005

Study Completion Date

June 30, 2005

Conditions

Hypertension

Interventions

DRUG

aliskiren

Trial Locations (2)

Novartis Pharmaceuticals, East Hanover

Investigative Centers